Skip to main content
SpringerLink
Log in

Mumps and Other Types of Viral Parotitis

  • Chapter
  • First Online:
Infections of the Ears, Nose, Throat, and Sinuses

  • 1504 Accesses

Abstract

Mumps is the most common cause of epidemic parotitis. Although vaccination has greatly reduced the incidence and morbidity of mumps, outbreaks have occurred frequently among vaccinated populations over the past two decades. Unlike outbreaks in the pre-vaccine era, which primarily affected children, recent outbreaks have predominantly affected young adults. The diagnosis of mumps relies on clinical features and laboratory findings, and is usually not difficult in unvaccinated patients. However, laboratory diagnosis in vaccinated patients is challenging due to the limited value of serologic studies and the brief window of time during which the virus can be detected in oral specimens. This chapter reviews the clinical and laboratory features of mumps as well as other viral etiologies of parotitis, including influenza virus, adenovirus, Epstein-Barr virus, parainfluenza virus, and enterovirus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tsoucalas G, Laios K, Karamanou M, Androutsos G. The Thasian epidemic 5th century BC. Infez Med. 2013;21(2):149–50.

    PubMed  Google Scholar 

  2. Johnson CD, Goodpasture EW. An investigation of the etiology of mumps. J Exp Med. 1934;59(1):1–19.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Johnson CD, Goodpasture EW. The etiology of mumps. Am J Hyg. 1935;21:46–57.

    Google Scholar 

  4. Rubin SA, Sauder CJ, Carbone KM. Mumps virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1024–41.

    Google Scholar 

  5. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330(7500):1132–5.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Centers for Disease Control and Prevention. Mumps cases and outbreaks. Atlanta, GA: Centers for Disease Control and Prevention; 2018.

    Google Scholar 

  7. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77(1):3–14.

    PubMed  PubMed Central  CAS  Google Scholar 

  8. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect. 2000;125(3):635–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Wagenvoort JH, Harmsen M, Boutahar-Trouw BJ, Kraaijeveld CA, Winkler KC. Epidemiology of mumps in the Netherlands. J Hyg (Lond). 1980;85(3):313–26.

    Article  CAS  Google Scholar 

  10. Morgan-Capner P, Wright J, Miller CL, Miller E. Surveillance of antibody to measles, mumps, and rubella by age. BMJ. 1988;297(6651):770–2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Janaszek-Seydlitz W, Bucholc B, Gorska P, Slusarczyk J. Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Vaccine. 2005;23(21):2711–6.

    Article  PubMed  Google Scholar 

  12. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82(7):51–60.

    Google Scholar 

  13. CDC. Brief report: update: mumps activity – United States, January 1–October 7, 2006. MMWR Morb Mortal Wkly Rep. 2006;55(42):1152–3.

    Google Scholar 

  14. Castilla J, Garcia Cenoz M, Barricarte A, Irisarri F, Núñez-Córdoba J, Barricarte A. Mumps outbreak in Navarre region, Spain, 2006–2007. Euro Surveill. 2007;12(2):E070215.1.

    PubMed  CAS  Google Scholar 

  15. Bangor-Jones RD, Dowse GK, Giele CM, Van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated aboriginal people in the Kimberley region of Western Australia. Med J Aust. 2009;191(7):398–401.

    PubMed  Google Scholar 

  16. Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Eur Secur. 2010;15(50):19748.

    Google Scholar 

  17. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel’s highly vaccinated society: are two doses enough? Epidemiol Infect. 2012;140(3):439–46.

    Article  PubMed  CAS  Google Scholar 

  18. Braeye T, Linina I, De Roy R, Hutse V, Wauters M, Cox P, et al. Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students. Vaccine. 2014;32(35):4393–8.

    Article  PubMed  Google Scholar 

  19. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Eur Secur. 2010;15(17):11–4.

    Google Scholar 

  20. Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20.

    Article  PubMed  PubMed Central  Google Scholar 

  21. World Health Organization. Mumps virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87:217–24.

    Google Scholar 

  22. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis. 2011;204(9):1413–22.

    Article  PubMed  CAS  Google Scholar 

  23. Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198(4):508–15.

    Article  PubMed  Google Scholar 

  24. Gouma S, ten Hulscher H, Schurink-van ‘t Klooster TM, de Melker HE, Boland GJ, Kaaijk P, et al. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection. Vaccine. 2016;34(35):4166–71.

    Article  PubMed  CAS  Google Scholar 

  25. Greenland K, Whelan J, Fanoy E, Borgert M, Hulshof K, Yap KB, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine. 2012;30(31):4676–80.

    Article  PubMed  Google Scholar 

  26. Anderson LJ, Seward JF. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J. 2008;27(10 Suppl):S75–9.

    Article  PubMed  Google Scholar 

  27. Jick H, Chamberlin DP, Hagberg KW. The origin and spread of a mumps epidemic. Epidemiology. 2009;20(5):656–61.

    Article  PubMed  Google Scholar 

  28. Huang AS, Cortese MM, Curns AT, Bitsko RH, Jordan HT, Soud F, et al. Risk factors for mumps at a university with a large mumps outbreak. Public Health Rep. 2009;124(3):419–26.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gouma S, Schurink-van ‘t Klooster TM, de Melker HE, Kerkhof J, Smits GP, SJM H, et al. Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students. Open Forum Infect Dis. 2014;1(3):ofu101.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Centers for Disease Control and Prevention. Mumps. Atlanta, GA: Centers for Disease Control and Prevention; 2017.

    Google Scholar 

  31. Ennis F, Jackson D. Isolation of virus during the incubation period of mumps infection. J Pediatr. 1968;72(4):536–7.

    Article  PubMed  CAS  Google Scholar 

  32. Tan KE, Anderson M, Krajden M, Petric M, Mak A, Naus M. Mumps virus detection during an outbreak in a highly vaccinated population in British Columbia. Can J Pub Heal. 2011;102(1):47–50.

    Google Scholar 

  33. Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep. 2008;57(40):1103–5.

    Google Scholar 

  34. Philip RN, Reinhard KR, Lackman DB. Observations on a mumps epidemic in a “virgin” population. 1958. Am J Epidemiol. 1995;142(3):233–53.

    Article  PubMed  CAS  Google Scholar 

  35. Rota JS, Rosen JB, Doll MK, McNall RJ, McGrew M, Williams N, et al. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York City in 2009. Clin Vaccine Immunol. 2013;20(3):391–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Zamir CS, Schroeder H, Shoob H, Abramson N, Zentner G. Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status of mumps outbreak cases. Hum Vaccin Immunother. 2015;11(6):1413–7.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371:932–44.

    Article  PubMed  Google Scholar 

  38. Dittrich S, Hahné S, van Lier A, Kohl R, Boot H, Koopmans M, et al. Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine. 2011;29(49):9271–5.

    Article  PubMed  Google Scholar 

  39. Tae BS, Ham BK, Kim JH, Park JY, Bae JH. Clinical features of mumps orchitis in vaccinated postpubertal males: a single-center series of 62 patients. Korean J Urol. 2012;53(12):865–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med. 2006;99(11):573–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Bjorvatn B. Mumps virus recovered from testicles by fine-needle aspiration biopsy in cases of human orchitis. Scand J Infect Dis. 1973;5(1):3–5.

    Article  PubMed  CAS  Google Scholar 

  42. Jalal H, Bahadur G, Knowles W, Jin L, Brink N. Mumps epididymo-orchitis with prolonged detection of virus in semen and the development of anti-sperm antibodies. J Med Virol. 2004;73(1):147–50.

    Article  PubMed  CAS  Google Scholar 

  43. Clifford V, Wadsley J, Jenner B, Buttery JP. Mumps vaccine associated orchitis: evidence supporting a potential immune-mediated mechanism. Vaccine. 2010;28(14):2671–3.

    Article  PubMed  CAS  Google Scholar 

  44. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002–2006. Emerg Infect Dis. 2011;17(4):661–7.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Orlíková H, Malý M, Lexová P, Šebestová H, Limberková R, Jurzykowská L, et al. Protective effect of vaccination against mumps complications, Czech Republic, 2007–2012. BMC Public Health. 2016;16(1):293.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Hahné S, Whelan J, van Binnendijk R, Swaan C, Fanoy E, Boot H, et al. Mumps vaccine effectiveness against orchitis. Emerg Infect Dis. 2012;18(1):191–3.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med. 2012;367(18):1704–13.

    Article  PubMed  CAS  Google Scholar 

  48. Sullivan KM, Halpin TJ, Kim-Farley R, Marks JS. Mumps disease ands its health impact: an outbreak based report. Pediatrics. 1985;76(4):533–6.

    PubMed  CAS  Google Scholar 

  49. Falk WA, Buchan K, Dow M, Garson JZ, Hill E, Nosal M, et al. The epidemiology of mumps in southern Alberta 1980–1982. Am J Epidemiol. 1989;130(4):736–49.

    Article  PubMed  CAS  Google Scholar 

  50. Kabakus N, Aydinoglu H, Yekeler H, Arslan I. Fatal mumps nephritis and myocarditis. J Trop Pediatr. 1999;45(6):358–60.

    Article  PubMed  CAS  Google Scholar 

  51. Gut JP, Lablache C, Behr S, Kirn A. Symptomatic mumps virus reinfections. J Med Virol. 1995;45(1):17–23.

    Article  PubMed  CAS  Google Scholar 

  52. Centers for Disease Control and Prevention. Mumps 2012 case definition. http://wwwn.cdc.gov/nndss/conditions/mumps/case-definition/2012/

  53. Centers for Disease Control and Prevention. Laboratory confonfirmation by IgM serology and questions and answers [Internet]. http://www.cdc.gov/mumps/lab/overview-serology.html

  54. Krause I, Wu R, Sherer Y, Patanik M, Peter JB, Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations—a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med. 2002;12(2):133–9.

    Article  PubMed  CAS  Google Scholar 

  55. Suga K, Goji A, Shono M, Matsuura S, Inoue M, Toda E, et al. Mumps encephalitis with akinesia and mutism. Pediatr Int. 2015;57(4):721–4.

    Article  PubMed  Google Scholar 

  56. Erpenbach K. Systemic treatment with interferon-alpha 2B: an effective method to prevent sterility after bilateral mumps orchitis. J Urol. 1991;146(1):54–6.

    Article  PubMed  CAS  Google Scholar 

  57. Ku J, Kim Y, Jeon Y, Lee N. The preventive effect of systemic treatment with interferon-alpha2B for infertility from mumps orchitis. BJU Int. 1999;84(7):839–42.

    Article  PubMed  CAS  Google Scholar 

  58. Yeniyol CO, Sorguc S, Minareci S, Ayder AR. Role of interferon-alpha-2B in prevention of testicular atrophy with unilateral mumps orchitis. Urology. 2000;55(6):931–3.

    Article  PubMed  CAS  Google Scholar 

  59. Kaaijk P, van der Zeijst B, Boog M, Hoitink C. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill. 2008;13(26):pii: 18914.

    Google Scholar 

  60. Buynak E, Hilleman M. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med. 1966;123(3):768–75.

    Article  PubMed  CAS  Google Scholar 

  61. Afzal MA, Pickford AR, Forsey T, Minor PD. Heterogeneous mumps vaccine. Lancet. 1992;340(8825):980–1.

    Article  PubMed  CAS  Google Scholar 

  62. Afzal MA, Pickford AR, Forsey T, Heath AB, Minor PD. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol. 1993;74(Pt 5):917–20.

    Article  PubMed  CAS  Google Scholar 

  63. Chambers P, Rima BK, Duprex WP. Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol. 2009;90(12):2973–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine. 2008;26(29–30):3601–7.

    Article  PubMed  Google Scholar 

  65. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004–2005 mumps outbreak. Engl Emerg Infect Dis. 2007;13(1):12–7.

    Google Scholar 

  66. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine. 2005;23(31):4070–4.

    Article  PubMed  CAS  Google Scholar 

  67. Snijders BEP, van Lier A, van de Kassteele J, Fanoy EB, Ruijs WLM, Hulshof F, et al. Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008. Vaccine. 2012;30(19):2999–3002.

    Article  PubMed  Google Scholar 

  68. Sartorius B, Penttinen P, Nilsson J, Johansen K, Jönsson K, Arneborn M, et al. An outbreak of mumps in Sweden, February–April 2004. Eur Secur. 2005;10(9):559.

    Google Scholar 

  69. Schaffzin JK, Pollock L, Schulte C, Henry K, Dayan G, Blog D, et al. Effectiveness of previous mumps vaccination during a summer camp outbreak. Pediatrics. 2007;120(4):e862–8.

    Article  PubMed  Google Scholar 

  70. Livingston KA, Rosen JB, Zucker JR, Zimmerman CM. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. Vaccine. 2014;32(3):369–74.

    Article  PubMed  Google Scholar 

  71. Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. Immune responses to mumps vaccine in adults who were vaccinated in childhood. J Infect Dis. 2008;197(2):1669–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis. 2001;184(7):817–26.

    Article  PubMed  CAS  Google Scholar 

  73. Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis. 2007;196(6):861–7.

    Article  PubMed  CAS  Google Scholar 

  74. Christenson B, Böttiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus. Biologicals. 1990;18(3):213–9.

    Article  PubMed  CAS  Google Scholar 

  75. Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, Waaijenborg S, et al. Seroprevalence of mumps in the Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS One. 2013;8(3):e58234.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis. 2012;206(10):1542–8.

    Article  PubMed  CAS  Google Scholar 

  77. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis. 2005;191(5):719–23.

    Article  PubMed  Google Scholar 

  78. Barrabeig I, Costa J, Rovira A, Marcos MA, Isanta R, Cervilla A, et al. Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain. Hum Vaccin Immunother. 2014;11(1):282–7.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Barskey AE, Juieng P, Whitaker BL, Erdman DD, Oberste MS, Chern SWW, et al. Viruses detected among sporadic cases of parotitis, United States, 2009–2011. J Infect Dis. 2013;208(12):1979–86.

    Article  PubMed  CAS  Google Scholar 

  80. Hatchette TF, Mahony JB, Chong S, LeBlanc JJ. Difficulty with mumps diagnosis: what is the contribution of mumps mimickers? J Clin Virol. 2009;46(4):381–3.

    Article  PubMed  Google Scholar 

  81. Krilov L, Swenson P. Acute parotitis associated with influenza A infection. J Infect Dis. 1985;152(4):853.

    Article  PubMed  CAS  Google Scholar 

  82. Liu WK, Liu Q, Chen DH, Liang HX, Chen XK, Huang WB, et al. Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infect Dis. 2013;13:28.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Frost HM, Robinson CC, Dominguez SR. Epidemiology and clinical presentation of parainfluenza type 4 in children: a 3-year comparative study to parainfluenza types 1–3. J Infect Dis. 2014;209(5):695–702.

    Article  PubMed  Google Scholar 

  84. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. 2016–2017 influenza update for health care providers: parotitis and influenza. Atlanta, GA: Centers for Disease Control and Prevention; 2016.

    Google Scholar 

  85. Yoshida M, Higuchi T. Herpes zoster ophthalmicus with ipsilateral parotitis. Int J Dermatol. 2013;52(6):769–70.

    Article  PubMed  Google Scholar 

  86. Lewis JM, Utz JP. Orchitis, parotitis and meningoencephalitis due to lymphocytic-choriomeningitis virus. N Engl J Med. 1961;265:776–80.

    Article  PubMed  CAS  Google Scholar 

  87. Wilson KF, Meier JD, Ward PD. Salivary gland disorders. Am Fam Physician. 2007;89(11):882–8.

    Google Scholar 

  88. Schiødt M. HIV-associated salivary gland disease: a review. Oral Surg Oral Med Oral Pathol. 1992;73(2):164–7.

    Article  PubMed  Google Scholar 

  89. Mandel L, Surattanont F. Bilateral parotid swelling: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(3):221–37.

    Article  PubMed  Google Scholar 

  90. Jeffers L, Webster-Cyriaque JY. Viruses and salivary gland disease (SGD): lessons from HIV SGD. Adv Dent Res. 2011;23(1):79–83.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  91. Shivhare P, Shankarnarayan L, Jambunath U, Malligene Basavarju S. Benign lymphoepithelial cysts of parotid and submandibular glands in a HIV-positive patient. J Oral Maxillofac Pathol. 2015;19:107.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Sujatha D, Babitha K, Prasad RS, Pai A. Parotid lymphoepithelial cysts in human immunodeficiency virus: a review. J Laryngol Otol. 2013;127:1046–9.

    Article  PubMed  CAS  Google Scholar 

  93. Shanti RM, Aziz SR. HIV-associated salivary gland disease. Oral Maxillofac Surg Clin N Am. 2009;21:339–43.

    Article  Google Scholar 

  94. Dave SP, Pernas FG, Roy S. The benign lymphoepithelial cyst and a classification system for lyphocytic parotid gland enlargement in the pediatric HIV population. Laryngoscope. 2007;117:106–13.

    Article  PubMed  Google Scholar 

  95. Syebele K, Butow KW. Comparative study of the effect of antiretroviral therapy on benign lymphoepithelial cyst of parotid glands and ranulas in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:205–10.

    Article  PubMed  Google Scholar 

  96. Gelfand MS, Cleveland KO, Lancaster D, Corbett CE, Florendo NT. Adenovirus parotitis in patients with AIDS. Clin Infect Dis. 1994;19(6):1045–8.

    Article  PubMed  CAS  Google Scholar 

  97. Crumpacker II, Clyde S. Cytomegalovirus (CMV). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Dougla, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia, PA: Elsevier (Saunders); 2015.

    Google Scholar 

  98. Greenberg MS, Glick M, Nghiem L, Stewart JC, Hodinka R, Dubin G. Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(3):334–9.

    Article  PubMed  CAS  Google Scholar 

  99. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med. 2003;14(2):115–27.

    Article  PubMed  CAS  Google Scholar 

  100. Carrozzo M, Scally K. Oral manifestations of hepatitis C virus infection. World J Gastroenterol. 2014;20(24):7534–43.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Grossmann SM, Teixeira R, Oliveira GC, Gleber-Netto FO, Araújo FM, Araújo FM, et al. Xerostomia, hyposalivation and sialadenitis in patients with chronic hepatitis C are not associated with the detection of HCV RNA in saliva or salivary glands. J Clin Pathol. 2010;63(11):1002–7.

    Article  CAS  Google Scholar 

  102. Schreiber A, Hershman G. Non-HIV viral infections of the salivary glands. Oral Maxillofac Surg Clin North Am. 2009;21(3):331–8.

    Article  PubMed  Google Scholar 

  103. Croia C, Astorri E, Murray-Brown W, Willis A, Brokstad KA, Sutcliffe N, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren’s syndrome. Arthritis Rheumatol. 2014;66(9):2545–57.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Sigrid Gouma

  2. Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Marlene L. Durand

  3. Infectious Disease Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA

    Marlene L. Durand

  4. Center for Infectious Disease Research, Diagnostics and Screening, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands

    Rob S. van Binnendijk

Authors
  1. Sigrid Gouma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlene L. Durand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rob S. van Binnendijk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rob S. van Binnendijk .

Editor information

Editors and Affiliations

  1. Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Marlene L. Durand

  2. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA

    Daniel G. Deschler

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gouma, S., Durand, M.L., van Binnendijk, R.S. (2018). Mumps and Other Types of Viral Parotitis. In: Durand, M., Deschler, D. (eds) Infections of the Ears, Nose, Throat, and Sinuses. Springer, Cham. https://doi.org/10.1007/978-3-319-74835-1_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74835-1_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74834-4

  • Online ISBN: 978-3-319-74835-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation